Design, methods and demographics from phase I of Alberta's Tomorrow Project cohort: a prospective cohort profile

Paula J Robson1, Nathan M Solbak1, Tiffany R Haig1

  • 1Cancer Measurement, Outcomes, Research and Evaluation (Robson), CancerControl Alberta, Alberta Health Services; Department of Agricultural, Food and Nutritional Science (Robson), Faculty of Agricultural, Life and Environmental Sciences, University of Alberta, Edmonton, Alta.; Cancer Measurement, Outcomes, Research and Evaluation (Solbak, Haig, Whelan, Vena, Akawung, Rosner), CancerControl Alberta, Alberta Health Services; Department of Cancer Epidemiology and Prevention Research (Brenner, Friedenreich, Csizmadi, Kopciuk), CancerControl Alberta, Alberta Health Services; Department of Oncology and Department of Community Health Sciences (Brenner, Friedenreich, Csizmadi), Cumming School of Medicine, University of Calgary, Health Sciences Centre, Calgary, Alta.; Department of Internal Medicine (Cook), University of New Mexico, Albuquerque, NM; Departments of Oncology and Mathematics and Statistics (Kopciuk), University of Calgary, Calgary, Alta.; Population, Public and Aboriginal Health (McGregor), Alberta Health Services, Calgary, Alta.

CMAJ Open
|October 13, 2016
PubMed
Abstract

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
199
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.6K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.3K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K